EP2099295A4 - Prophylaxie et traitement de la fibrillation auriculaire avec des acides gras oméga-3 - Google Patents
Prophylaxie et traitement de la fibrillation auriculaire avec des acides gras oméga-3Info
- Publication number
- EP2099295A4 EP2099295A4 EP07862162A EP07862162A EP2099295A4 EP 2099295 A4 EP2099295 A4 EP 2099295A4 EP 07862162 A EP07862162 A EP 07862162A EP 07862162 A EP07862162 A EP 07862162A EP 2099295 A4 EP2099295 A4 EP 2099295A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- prophlyaxis
- omega
- treatment
- fatty acids
- atrial fibrillation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86049506P | 2006-11-22 | 2006-11-22 | |
PCT/US2007/024283 WO2008066745A1 (fr) | 2006-11-22 | 2007-11-21 | Prophylaxie et traitement de la fibrillation auriculaire avec des acides gras oméga-3 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2099295A1 EP2099295A1 (fr) | 2009-09-16 |
EP2099295A4 true EP2099295A4 (fr) | 2010-02-24 |
Family
ID=39468221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP07862162A Withdrawn EP2099295A4 (fr) | 2006-11-22 | 2007-11-21 | Prophylaxie et traitement de la fibrillation auriculaire avec des acides gras oméga-3 |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2099295A4 (fr) |
JP (1) | JP2010510313A (fr) |
WO (1) | WO2008066745A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20012384A1 (it) | 2001-11-12 | 2003-05-12 | Quatex Nv | Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori |
US8974828B2 (en) * | 2009-03-18 | 2015-03-10 | Incarda Therapeutics, Inc. | Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration |
JPWO2012108379A1 (ja) * | 2011-02-07 | 2014-07-03 | 持田製薬株式会社 | 拡張性うっ血性心不全治療剤 |
GB2581301A (en) | 2016-02-01 | 2020-08-12 | Incarda Therapeutics Inc | Combining electronic monitoring with inhaled pharmacological therapy to manage atrial arrhythmias including atrial fibrillation |
IL270407B2 (en) | 2017-05-10 | 2024-03-01 | Incarda Therapeutics Inc | Dosage units, sprays, kits and methods for treating heart conditions through pulmonary administration |
EP3768378A4 (fr) | 2018-03-22 | 2021-11-17 | InCarda Therapeutics, Inc. | Nouvelle méthode pour ralentir le rythme ventriculaire |
US11007185B2 (en) | 2019-08-01 | 2021-05-18 | Incarda Therapeutics, Inc. | Antiarrhythmic formulation |
RU2722052C1 (ru) * | 2019-12-30 | 2020-05-26 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Самарский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Способ определения риска развития фибрилляции предсердий у пациентов с ишемической болезнью сердца, принимающих омега-3 полиненасыщенные жирные кислоты, при проведении коронарного шунтирования |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040044028A1 (en) * | 2001-03-30 | 2004-03-04 | Obukowicz Mark G. | Combinations of omega-3 fatty acids and cyclooxygenase-2 inhibitors for treatment or prevention of cardiovascular disease and treatment or prevention of cancer |
US20030144219A1 (en) * | 2001-11-15 | 2003-07-31 | Phinney Stephen Dodge | Formulations and methods for treatment or amelioration of inflammatory conditions |
US8729124B2 (en) * | 2002-03-05 | 2014-05-20 | Pronova Biopharma Norge As | Use of EPA and DHA in secondary prevention |
ITMI20022511A1 (it) * | 2002-11-26 | 2004-05-27 | Victorix Assets Ltd | Uso di composizioni farmaceutiche contenenti esteri etilici di acidi poliinsaturi omega-3 nella orevenzione della fibrillazione atriale. |
WO2004100964A1 (fr) | 2003-04-24 | 2004-11-25 | Aderis Pharmaceuticals, Inc. | Methode de traitement de la fibrillation auriculaire ou du flutter auriculaire |
-
2007
- 2007-11-21 WO PCT/US2007/024283 patent/WO2008066745A1/fr active Application Filing
- 2007-11-21 EP EP07862162A patent/EP2099295A4/fr not_active Withdrawn
- 2007-11-21 JP JP2009538407A patent/JP2010510313A/ja active Pending
Non-Patent Citations (3)
Title |
---|
BISCIONE FRANCESCO ET AL: "[Effect of omega-3 fatty acids on the prevention of atrial arrhythmias]", ITALIAN HEART JOURNAL. SUPPLEMENT : OFFICIAL JOURNAL OF THE ITALIAN FEDERATION OF CARDIOLOGY JAN 2005, vol. 6, no. 1, January 2005 (2005-01-01), pages 53 - 59, XP009127037, ISSN: 1129-4728 * |
KATAN MARTIJN B ET AL: "Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: An 18-month controlled study", JOURNAL OF LIPID RESEARCH, vol. 38, no. 10, 1997, pages 2012 - 2022, XP002560498, ISSN: 0022-2275 * |
See also references of WO2008066745A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO2008066745A9 (fr) | 2008-08-28 |
WO2008066745A1 (fr) | 2008-06-05 |
JP2010510313A (ja) | 2010-04-02 |
EP2099295A1 (fr) | 2009-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2099295A4 (fr) | Prophylaxie et traitement de la fibrillation auriculaire avec des acides gras oméga-3 | |
EP1904049A4 (fr) | Acides gras polyinsatures pour le traitement de la demence et d'etats predementiels | |
ZA201003030B (en) | Medium-chain length fatty acids and glycerides as nephroprotection agents | |
EP2136844A4 (fr) | Compositions comprenant des monoglycérides d'acides gras polyinsaturés ou des dérivés de ceux-ci et leurs utilisations | |
EP2089014A4 (fr) | Acides gras oméga-3 et agent dyslipidémique pour la réduction des niveaux d'apo-b | |
EP2120920A4 (fr) | Oxylipines derivées d'acides gras polyinsaturés à chaîne longue et leurs procédé de production et d'utilisation | |
EP2083815A4 (fr) | Statine et acides gras oméga-3 pour la réduction des niveaux d'apo-b | |
EP1919468A4 (fr) | Traitement au moyen d'inhibiteurs d'absorption de cholesterol a base d'azetidinone et d'acide gras omega-3 et produit de combinaison de ceux-ci | |
ZA201303962B (en) | Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas | |
EP2083622A4 (fr) | Procédés d'utilisation d'acides gras oméga-3 pour réduire les taux de lp-pla2 | |
EP2240017A4 (fr) | Corps cétoniques et esters de corps cétoniques convenant comme hypolipémiants sanguins | |
EP1861087A4 (fr) | Traitement avec une statine et des acides gras omega 3 et produit de combinaison correspondant | |
EP2173699A4 (fr) | Production et purification d'esters d'acides gras polyinsaturés | |
PL2214638T3 (pl) | Kompozycja zawierająca wielonienasycone kwasy tłuszczowe i węgiel aktywny | |
GB0915693D0 (en) | Fatty acid formulations and methods of use thereof | |
IL210318A (en) | Acetylation fatty acid salicylates and their uses | |
IL219874A0 (en) | Capsules of active pharmaceutical ingredients and polyunsaturated fatty acid esters for the treatment of cardiovascular diseases | |
IL207309A (en) | Lipases with high specificity towards short chain fatty acids and uses thereof | |
EP2324119A4 (fr) | Delta5 désaturases mutantes et leur utilisation dans la production d'acides gras polyinsaturés | |
SI2034999T1 (sl) | DHA estri in uporaba le-teh pri zdravljenju in preprečevanju kardiovaskularnih bolezni | |
EP2114397A4 (fr) | Nouveaux conjugués d'acides gras poly-insaturés avec des amines et utilisations thérapeutiques de ceux-ci | |
ZA200807341B (en) | Fatty acid by-products and methods of using same | |
GB2464886B (en) | Preparation of fatty acids in solid form | |
PL2390339T3 (pl) | Delta-8 desaturazy i ich zastosowanie w wytwarzaniu polinienasyconych kwasów tłuszczowych | |
ZA200807296B (en) | Fatty acid by-products and methods of using same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20090618 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: HR |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 9/06 20060101ALI20100105BHEP Ipc: A61K 45/06 20060101ALI20100105BHEP Ipc: A61K 31/202 20060101AFI20100105BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20100122 |
|
RAX | Requested extension states of the european patent have changed |
Extension state: HR Payment date: 20090618 |
|
17Q | First examination report despatched |
Effective date: 20100331 |
|
TPAC | Observations filed by third parties |
Free format text: ORIGINAL CODE: EPIDOSNTIPA |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20100811 |